Navigation Links
Vanderbilt study reveals clues to childhood respiratory virus

New Vanderbilt-led research published in the Feb. 14 issue of the New England Journal of Medicine has identified the relatively unknown human metapneumovirus (MPV) as the second most common cause of severe bronchiolitis in young children.

Senior author John Williams , M.D., associate professor of Pediatric Infectious Diseases and a well-known expert in MPV research, said it is gratifying to offer a clearer picture of how this virus impacts children.

"We found MPV is as important a cause of respiratory illness as influenza, and caused more illness than the three common types of parainfluenza virus combined. In fact, in young children, the burden of MPV was second only to RSV (respiratory syncytial virus) as a cause of bronchiolitis," Williams said.

The prospective research spanned six years, from 2003 to 2009, and involved samples taken from more than 10,000 children under age 5. The children were hospitalized, treated in an emergency department, or seen in an outpatient clinic with a lower respiratory infection (bronchiolitis).

Lead author Kathryn Edwards, M.D., the Sarah H. Sell and Cornelius Vanderbilt Chair in Pediatrics and director of the Vanderbilt Vaccine Research Program, led the clinical portion of the study while Williams' laboratory tested the samples for their viral content.

Three New Vaccine Surveillance Network (NVSN) sites participated: Rochester, N.Y., Cincinnati and Nashville, making this the largest prospective trial to date to investigate the burden of MPV.

Researchers found MPV tends to affect more children over age 1 than RSV, and while both viral infections strike in late winter or spring, MPV has a seasonal peak that lags behind the typical peak for RSV by about a month. The authors said physicians commonly see patients with this virus, but know little about it.

"It is important to understand the burden of disease caused by human metapneumovirus so that we can work on vaccines to prevent them. We want to understand the enemy so that we can counteract it," said Edwards.

MPV was first described in 2001 and there are no specific treatments or vaccines for it other than supportive care for bronchiolitis, such as oxygen, bronchodilators and intravenous fluids. No children involved in this study died from their infections. Williams said this is generally true for all the major causes of bronchiolitis in the United States because of the level of medical care available in this country.

"But in developing nations worldwide, lower respiratory illness is a leading cause of death in young children. Only diarrhea kills more children under the age of 5. We can infer, because of this study, that MPV is a major contributor to these deaths worldwide. We hope this will help stimulate more interest in research on vaccines and treatment for MPV," Williams said.


Contact: Craig Boerner
Vanderbilt University Medical Center

Related medicine news :

1. Vanderbilt study examines Affordable Care Acts impact on uncompensated care
2. Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
3. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
4. Vanderbilt study looks at benefits of progestogens to prevent early childbirth
5. Vanderbilt-led study reveals racial disparities in prostate cancer care
6. Vanderbilt researchers find proteins may point way to new prostate cancer drug targets
7. Vanderbilt study finds obesity linked to kidney injury after heart surgery
8. Outdoor Fast-Food Ads Linked to Obesity, Study Suggests
9. Key molecule suppresses growth of cancerous liver tumors, Mayo study finds
10. Cyberbullying as Harmful as Physical Threats, Study Finds
11. MIND Institute researchers receive $1 million grant to study cognitive training in fragile X
Post Your Comments:
(Date:12/1/2015)... HANGZHOU, China (PRWEB) , ... December 01, 2015 , ... ... will result in its largest order to date. , The order will be ... implant systems. Nurotron’s Venus Cochlear Implant System is an effective solution for children and ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... Trust on receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. ... the patient care experience, and propose exciting enhancements to the medical landscape. , ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... engine optimization companies, announced today that it has officially launched a sleek, mobile-ready ... SEO, explained that his company’s new website clearly outlines the benefits that its ...
(Date:11/30/2015)... NC (PRWEB) , ... November 30, 2015 , ... Trevor ... corporate support as they play for the chance to represent the United States. This ... the opportunity to be a part of their journey in addition to offering corporate ...
(Date:11/30/2015)... ... December 01, 2015 , ... The ... a 2015-2016 inductee into its VIP Woman of the Year Circle. She is ... leading networking organization exclusively for professional women, boasting 850,000 members and over 200 ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
(Date:11/30/2015)... , 1 décembre 2015 ... exposition et conférence d,Asie portant sur ... sur l,industrie manufacturière, se tiendra à ... 20 au 22 avril 2016. ... Photo - ...
(Date:11/30/2015)... PUNE, India , December 1, 2015 ... --> adds "Endometriosis - ... that provides an overview on therapeutic pipeline ... capabilities to create effective counter strategies to ... by identifying new targets and MOAs to ...
Breaking Medicine Technology: